Trastuzumab biosimilar PBS-listed
Among its indications are for patients with HER2-positive advanced adenocarcinoma of the stomach
16th August 2019
By Clare Pain
A biosimilar of trastusumab, Ogivri (Mylan), was listed on the PBS on 1 August.
Log In
Welcome to AusDoc.Plus, the new home of Australian Doctor, Medical Observer, 6minutes and How to Treat. You can use your existing login credentials for any of these sites to gain entry.
Not a member?
Join AusDoc.PLUS
Register
To ensure you get the right membership, please select your vocation: